The principal enzyme of the polyol pathway, AR, has been identified as a critical mediator of oxidative and inflammatory signaling, as well as endothelial dysfunction, triggered by growth factors, cytokines, and hyperglycemia [21], preventable through AR inhibition [19]. Here, AR is linked to endothelial dysfunction.